Denis Chem Lab Complete Financial Statements
In FY2026, Denis Chem Lab (DENISCHEM) reported revenue ₹182 Cr, net profit ₹8 Cr and EPS ₹6.06, with a net profit margin of 4.4% and ROE of 8.7%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Also explore DENISCHEM share price history to track price trends across different timeframes.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
DENISCHEM Revenue, Net Profit & EBITDA — Year-on-Year Growth
DENISCHEM YoY (March 2025 vs March 2026) — revenue +3.4%, EBITDA -5.3%, expenses +4.5%. Analyse Denis Chem Lab shareholding analysis to track promoter, FII and institutional holdings.
DENISCHEM Income Statement — Revenue, EBITDA & Net Profit
Denis Chem Lab revenue ₹182 Cr, EBITDA ₹18 Cr, net profit ₹8 Cr, EPS ₹6.06 (2026) — net profit margin 4.4%. For live price, earnings ratios and company overview, see Denis Chem Lab screener.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 182 | 176 | 169 | 161 | 138 | 110 | 136 | 126 | 108 | 114 | 100 | 77 |
| Expenses | 164 | 157 | 147 | 142 | 122 | 99 | 121 | 110 | 95 | 100 | 91 | 68 |
| EBITDA | 18 | 19 | 23 | 19 | 15 | 11 | 15 | 16 | 13 | 15 | 9 | 10 |
| Operating Profit Margin % | 10.00% | 9.00% | 13.00% | 12.00% | 11.00% | 9.00% | 11.00% | 11.00% | 11.00% | 12.00% | 9.00% | 12.00% |
| Depreciation | 7 | 7 | 7 | 8 | 6 | 6 | 7 | 6 | 6 | 7 | 6 | 4 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 5 | 6 | 7 | 5 |
| Profit Before Tax | 12 | 11 | 15 | 11 | 9 | 3 | 6 | 6 | 2 | 2 | -3 | 0 |
| Tax | 4 | 3 | 4 | 3 | 3 | 1 | 2 | 0 | 0 | 1 | 1 | 0 |
| Net Profit | 8 | 8 | 11 | 8 | 6 | 2 | 4 | 6 | 2 | 1 | -4 | 0 |
| Earnings Per Share (₹) | 6.06 | 5.82 | 8.04 | 5.66 | 4.51 | 1.63 | 3.03 | 4.58 | 1.69 | 1.07 | -4.92 | 0.09 |
DENISCHEM Balance Sheet — Assets, Liabilities & Shareholders' Equity
DENISCHEM total assets ₹125 Cr, total equity ₹92 Cr, total liabilities ₹ Cr (2026) — ROE 8.7%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 125 | 112 | 109 | 99 | 96 | 92 | 97 | 106 | 101 | 94 | 85 | 81 |
| Current Assets | 85 | 71 | 69 | 59 | 53 | 49 | 50 | 54 | 53 | 48 | 34 | 37 |
| Fixed Assets | 37 | 39 | 38 | 35 | 42 | 41 | 46 | 50 | 40 | 44 | 40 | 42 |
| Capital Work in Progress | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 5 | 1 | 10 | 0 |
| Investments | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 73 | 72 | 62 | 55 | 51 | 52 | 55 | 56 | 49 | 35 | 39 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 2 | 1 | 2 | 3 | 5 | 6 | 4 | 6 | 11 | 20 | 22 | 25 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 92 | 85 | 80 | 72 | 67 | 62 | 59 | 57 | 50 | 30 | 16 | 17 |
| Share Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 12 | 9 | 9 |
| Reserves & Surplus | 78 | 71 | 67 | 58 | 53 | 48 | 45 | 43 | 36 | 18 | 3 | 8 |
DENISCHEM Cash Flow Statement — Operating, Investing & Financing
Denis Chem Lab operating cash flow ₹12 Cr, investing ₹-8 Cr, financing ₹-4 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 12 | 18 | 16 | 17 | 8 | 13 | 8 | 11 | 7 | 21 | 14 |
| Investing Activities | -8 | -15 | -11 | -10 | -1 | -2 | -2 | -16 | -1 | -13 | -28 |
| Financing Activities | -4 | -4 | -4 | -7 | -6 | -14 | -5 | 1 | 0 | -7 | 13 |
| Net Cash Flow | 0 | -1 | 1 | 0 | 1 | -3 | 1 | -4 | 5 | 1 | -1 |